TME Pharma's Ordinary Shares
• Date of the IPO: September 28, 2016
*taking into account the shares issuance following conversion of CBs and issuance of 960,025 private placement shares
on 25 April 2023 related to the transaction as published on 18 April 2023.
TME Pharma N.V. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding TME Pharma’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of TME Pharma or its management. TME Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Rapid access to French brokers